Zusammenfassung
Hauptvertreter der Mineralstoffpräparate sind Calcium-, Kalium- und Magnesiumpräparate. Kaliumpräparate dienen der Korrektur eines höhergradigen Kaliummangels. Magnesiumpräparate sind bei Magnesiummangelzuständen indiziert die aber bei der weiten Verbreitung von Magnesium in der Nahrung bei üblicher Kost selten sind.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Medical Association (1986): Agents affecting calcium metabolism. In: Drug Evaluations, 6th ed, Saunders Company, Philadelphia, pp. 827–839, 885–902.
Arzneimittelkommission der Deutschen Ärzteschaft (2003): Empfehlungen zur Therapie und Prophylaxe der Osteoporose. Arzneiverordnung in der Praxis (Sonderheft 34S).
Bone HG, Greenspan SL, McKeever C et al (2000): Alendronate and estrogen effects in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab 85: 720–726.
Crowther CA, Hiller JE, Doyle LW, Haslam RR (2003): Effect of magnesium sulfate given for neuroprotection before preterm birth. JAMA 290:2669–2676.
Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997): Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670–676.
Fleisch H (2000): Bisphosphonates in bone disease. From the laboratory to the patient. 4th ed, Academic Press, San Diego etc., pp. 1–212.
Galloe AM, Rasmussen HS, Jorgensen LN, Aurup P, Balslov S et al (1993): Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction. Brit Med J 307:585–587.
Hersh AL, Stefanick ML, Stafford RS (2004): National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. JAMA 291: 47–53.
ISIS-4 Collaborative Group (1995): ISIS-4: a randomised Arctoriol trial assessing early oral Captopril, oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345:669–685.
Kuhlmann U, Siegenthaler W, Siegenthaler G (1987): Wasser-und Elektrolythaushalt. In: Siegenthaler W. (Hrsg): Klinische Pathophysiologie. Georg Thieme Verlag, Stuttgart New York, S. 209–237.
Manz M, Mletzko R, Jung W, Lüderitz B (1990): Behandlung von Herzrhythmusstörungen mit Magnesium. Dtsch Med Wschr 115: 386–390.
Meyer P, Boettger MB (2001): Familial hypomagnesaemia with second hypocalcemia: A new case that indicates autosomal recessive inheritance. J Inherit Metab Dis 24: 875–876.
Miller PD, Watts NB, Licata AA et al (1997): Cyclical etidronate in treatment of postmenopausal osteoporosis. Am J Med 103:468–476.
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al (2001): Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441.
NIH Consensus Conference (1994): Optimal calcium intake. JAMA 272:1942–1948.
Riggs BL, O’Fallon WM, Lane A, Hodgson SF, Wahner HW et al (1994): Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis. J Bone Miner Res 9: 265–275.
Wüster C, Ziegler R (1993): Fluorid-Therapie der Osteoporose: „Auf die Dosis kommt es an“. Dtsch Ärztebl 90: B-41–42.
Zehender M, Meinertz T, Faber T, Caspary A, Jeron A et al (1997): Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. J Am Coll Cardiol 29:1028–1034.
Ziegler R (2002): Osteoporose: aktuelle Diagnostik und Therapie. Orthopädische Praxis 38: 570–577.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwabe, U., Ziegler, R. (2004). Mineralstoffpräparate und Osteoporosemittel. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2004. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18513-7_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-18513-7_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21359-8
Online ISBN: 978-3-642-18513-7
eBook Packages: Springer Book Archive